Blog

Teresa Amaral: The fantastic group of the ESMO LGP Asia edition 2023-2024

Teresa Amaral/LinkedIn

Dec 10, 2024, 06:59

Teresa Amaral: The fantastic group of the ESMO LGP Asia edition 2023-2024

Teresa Amaral, Head of Skin Cancer Clinical Trials Center at University Hospital Tübingen, shared a post on LinkedIn:

“The fantastic group of the ESMO – European Society for Medical Oncology LGP Asia edition 2023-2024! It has been an honor and a privilege to lead this fantastic class.

There were so many eye-opening discussions today, listening to the myriad of experiences from the different backgrounds of this diverse group!

Learning and networking change your life as a medical oncologist and will impact your patients’ outcomes! Thanks, Ravindran Kanesvaran and Mel Valerie Cruz-Ordinario, for coming to the course and providing your insights.

I am looking forward to the next projects together!”

More posts featuring Teresa Amaral.

Teresa Amaral is a Consultant Medical Oncologist and the Head of Skin Cancer Clinical Trials Center at the Tuebingen University Hospital in Germany. Dr Amaral obtained her MD degree from Lisbon University in 2006, concurrent with her degree in Aeronautic Medicine from the Portuguese Air Force.

Following her graduation, she pursued her general internship at CHLN and Hospital Pulido Valente in Lisbon in 2007, followed by a Medical Oncology Internship in 2008. She is a board-certified Specialist in Medical Oncology since 2014. Between 2020 and 2022, Dr Amaral served as the Chair of the ESMO (European Society for Medical Oncology) Young Oncologists Committee.

Currently, she is member of the ESMO Melanoma and Other Skin Tumours Faculty and subject editor for melanoma and other skin cancers guidelines. Since January 2023 she is Chair of the ESMO Leadership Development Committee and serves as an ESMO Council Member.